The North American coagulation albumin market continues to hold a significant share of the global industry, driven by advanced healthcare infrastructure, rising prevalence of bleeding disorders, and increasing utilization of plasma-derived therapeutics. The region benefits from a strong network of plasma collection centers, favorable reimbursement policies, and continuous investments in...